Megalencephalic leukoencephalopathy with subcortical cysts protein-1 regulates epidermal growth factor receptor signaling in astrocytes

Angela Lanciotti, Maria Stefania Brignone, Sergio Visentin, Chiara De Nuccio, Luigi Catacuzzeno, Cinzia Mallozzi, Stefania Petrini, Martino Caramia, Caterina Veroni, Gaetana Minnone, Antonietta Bernardo, Fabio Franciolini, Mauro Pessia, Enrico Bertini, Tamara Corinna Petrucci, Elena Ambrosini

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Mutations in the MLC1 gene, which encodes a protein expressed in brain astrocytes, are the leading cause of MLC, a rare leukodystrophy characterized by macrocephaly, brain edema, subcortical cysts, myelin and astrocyte vacuolation. Although recent studies indicate that MLC1 protein is implicated in the regulation of cell volume changes, the exact role of MLC1 in brain physiology and in the pathogenesis of MLC disease remains to be clarified. In preliminary experiments, we observed that MLC1 was poorly expressed inhighly proliferating astrocytomacellswhencomparedwith primaryastrocytes, and thatmodulation ofMLC1 expression influenced astrocyte growth. Because volume changes are key events in cell proliferation and during brain development MLC1 expression is inversely correlated to astrocyte progenitor proliferation levels,we investigated the possible role for MLC1 in the control of astrocyte proliferation.We found that overexpression ofwild type but notmutantMLC1 in human astrocytomacells hampered cell growth by favoring epidermal growth factor receptor (EGFR) degradation and by inhibiting EGF-induced Ca+ entry, ERK1/2 and PLCγ1 activation, and calcium-activated KCa3.1 potassium channel function, all molecular pathways involved in astrocyte proliferation stimulation. Interestingly, MLC1 did not influence AKT, an EGFR-stimulated kinase involved in cell survival. Moreover, EGFR expressionwas higher inmacrophages derived fromMLC patients than fromhealthy individuals. Since reactive astrocytes proliferate and re-express EGFR in response to different pathological stimuli, the present findings provide new information on MLC pathogenesis and unravel an important role for MLC1 in other brain pathological conditions where astrocyte activation occurs.

Original languageEnglish
Article numberddw032
Pages (from-to)1543-1558
Number of pages16
JournalHuman Molecular Genetics
Volume25
Issue number8
DOIs
Publication statusPublished - Apr 15 2016

Fingerprint

Epidermal Growth Factor Receptor
Astrocytes
Proteins
Brain
Megalencephaly
Calcium-Activated Potassium Channels
Megalencephalic leukoencephalopathy with subcortical cysts
Brain Edema
Growth
Myelin Sheath
Cell Size
Epidermal Growth Factor
Cysts
Cell Survival
Cell Proliferation
Mutation
Genes

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Lanciotti, A., Brignone, M. S., Visentin, S., De Nuccio, C., Catacuzzeno, L., Mallozzi, C., ... Ambrosini, E. (2016). Megalencephalic leukoencephalopathy with subcortical cysts protein-1 regulates epidermal growth factor receptor signaling in astrocytes. Human Molecular Genetics, 25(8), 1543-1558. [ddw032]. https://doi.org/10.1093/hmg/ddw032

Megalencephalic leukoencephalopathy with subcortical cysts protein-1 regulates epidermal growth factor receptor signaling in astrocytes. / Lanciotti, Angela; Brignone, Maria Stefania; Visentin, Sergio; De Nuccio, Chiara; Catacuzzeno, Luigi; Mallozzi, Cinzia; Petrini, Stefania; Caramia, Martino; Veroni, Caterina; Minnone, Gaetana; Bernardo, Antonietta; Franciolini, Fabio; Pessia, Mauro; Bertini, Enrico; Petrucci, Tamara Corinna; Ambrosini, Elena.

In: Human Molecular Genetics, Vol. 25, No. 8, ddw032, 15.04.2016, p. 1543-1558.

Research output: Contribution to journalArticle

Lanciotti, A, Brignone, MS, Visentin, S, De Nuccio, C, Catacuzzeno, L, Mallozzi, C, Petrini, S, Caramia, M, Veroni, C, Minnone, G, Bernardo, A, Franciolini, F, Pessia, M, Bertini, E, Petrucci, TC & Ambrosini, E 2016, 'Megalencephalic leukoencephalopathy with subcortical cysts protein-1 regulates epidermal growth factor receptor signaling in astrocytes', Human Molecular Genetics, vol. 25, no. 8, ddw032, pp. 1543-1558. https://doi.org/10.1093/hmg/ddw032
Lanciotti, Angela ; Brignone, Maria Stefania ; Visentin, Sergio ; De Nuccio, Chiara ; Catacuzzeno, Luigi ; Mallozzi, Cinzia ; Petrini, Stefania ; Caramia, Martino ; Veroni, Caterina ; Minnone, Gaetana ; Bernardo, Antonietta ; Franciolini, Fabio ; Pessia, Mauro ; Bertini, Enrico ; Petrucci, Tamara Corinna ; Ambrosini, Elena. / Megalencephalic leukoencephalopathy with subcortical cysts protein-1 regulates epidermal growth factor receptor signaling in astrocytes. In: Human Molecular Genetics. 2016 ; Vol. 25, No. 8. pp. 1543-1558.
@article{2a0e290b1b914aecb5d17e84b962903e,
title = "Megalencephalic leukoencephalopathy with subcortical cysts protein-1 regulates epidermal growth factor receptor signaling in astrocytes",
abstract = "Mutations in the MLC1 gene, which encodes a protein expressed in brain astrocytes, are the leading cause of MLC, a rare leukodystrophy characterized by macrocephaly, brain edema, subcortical cysts, myelin and astrocyte vacuolation. Although recent studies indicate that MLC1 protein is implicated in the regulation of cell volume changes, the exact role of MLC1 in brain physiology and in the pathogenesis of MLC disease remains to be clarified. In preliminary experiments, we observed that MLC1 was poorly expressed inhighly proliferating astrocytomacellswhencomparedwith primaryastrocytes, and thatmodulation ofMLC1 expression influenced astrocyte growth. Because volume changes are key events in cell proliferation and during brain development MLC1 expression is inversely correlated to astrocyte progenitor proliferation levels,we investigated the possible role for MLC1 in the control of astrocyte proliferation.We found that overexpression ofwild type but notmutantMLC1 in human astrocytomacells hampered cell growth by favoring epidermal growth factor receptor (EGFR) degradation and by inhibiting EGF-induced Ca+ entry, ERK1/2 and PLCγ1 activation, and calcium-activated KCa3.1 potassium channel function, all molecular pathways involved in astrocyte proliferation stimulation. Interestingly, MLC1 did not influence AKT, an EGFR-stimulated kinase involved in cell survival. Moreover, EGFR expressionwas higher inmacrophages derived fromMLC patients than fromhealthy individuals. Since reactive astrocytes proliferate and re-express EGFR in response to different pathological stimuli, the present findings provide new information on MLC pathogenesis and unravel an important role for MLC1 in other brain pathological conditions where astrocyte activation occurs.",
author = "Angela Lanciotti and Brignone, {Maria Stefania} and Sergio Visentin and {De Nuccio}, Chiara and Luigi Catacuzzeno and Cinzia Mallozzi and Stefania Petrini and Martino Caramia and Caterina Veroni and Gaetana Minnone and Antonietta Bernardo and Fabio Franciolini and Mauro Pessia and Enrico Bertini and Petrucci, {Tamara Corinna} and Elena Ambrosini",
year = "2016",
month = "4",
day = "15",
doi = "10.1093/hmg/ddw032",
language = "English",
volume = "25",
pages = "1543--1558",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Megalencephalic leukoencephalopathy with subcortical cysts protein-1 regulates epidermal growth factor receptor signaling in astrocytes

AU - Lanciotti, Angela

AU - Brignone, Maria Stefania

AU - Visentin, Sergio

AU - De Nuccio, Chiara

AU - Catacuzzeno, Luigi

AU - Mallozzi, Cinzia

AU - Petrini, Stefania

AU - Caramia, Martino

AU - Veroni, Caterina

AU - Minnone, Gaetana

AU - Bernardo, Antonietta

AU - Franciolini, Fabio

AU - Pessia, Mauro

AU - Bertini, Enrico

AU - Petrucci, Tamara Corinna

AU - Ambrosini, Elena

PY - 2016/4/15

Y1 - 2016/4/15

N2 - Mutations in the MLC1 gene, which encodes a protein expressed in brain astrocytes, are the leading cause of MLC, a rare leukodystrophy characterized by macrocephaly, brain edema, subcortical cysts, myelin and astrocyte vacuolation. Although recent studies indicate that MLC1 protein is implicated in the regulation of cell volume changes, the exact role of MLC1 in brain physiology and in the pathogenesis of MLC disease remains to be clarified. In preliminary experiments, we observed that MLC1 was poorly expressed inhighly proliferating astrocytomacellswhencomparedwith primaryastrocytes, and thatmodulation ofMLC1 expression influenced astrocyte growth. Because volume changes are key events in cell proliferation and during brain development MLC1 expression is inversely correlated to astrocyte progenitor proliferation levels,we investigated the possible role for MLC1 in the control of astrocyte proliferation.We found that overexpression ofwild type but notmutantMLC1 in human astrocytomacells hampered cell growth by favoring epidermal growth factor receptor (EGFR) degradation and by inhibiting EGF-induced Ca+ entry, ERK1/2 and PLCγ1 activation, and calcium-activated KCa3.1 potassium channel function, all molecular pathways involved in astrocyte proliferation stimulation. Interestingly, MLC1 did not influence AKT, an EGFR-stimulated kinase involved in cell survival. Moreover, EGFR expressionwas higher inmacrophages derived fromMLC patients than fromhealthy individuals. Since reactive astrocytes proliferate and re-express EGFR in response to different pathological stimuli, the present findings provide new information on MLC pathogenesis and unravel an important role for MLC1 in other brain pathological conditions where astrocyte activation occurs.

AB - Mutations in the MLC1 gene, which encodes a protein expressed in brain astrocytes, are the leading cause of MLC, a rare leukodystrophy characterized by macrocephaly, brain edema, subcortical cysts, myelin and astrocyte vacuolation. Although recent studies indicate that MLC1 protein is implicated in the regulation of cell volume changes, the exact role of MLC1 in brain physiology and in the pathogenesis of MLC disease remains to be clarified. In preliminary experiments, we observed that MLC1 was poorly expressed inhighly proliferating astrocytomacellswhencomparedwith primaryastrocytes, and thatmodulation ofMLC1 expression influenced astrocyte growth. Because volume changes are key events in cell proliferation and during brain development MLC1 expression is inversely correlated to astrocyte progenitor proliferation levels,we investigated the possible role for MLC1 in the control of astrocyte proliferation.We found that overexpression ofwild type but notmutantMLC1 in human astrocytomacells hampered cell growth by favoring epidermal growth factor receptor (EGFR) degradation and by inhibiting EGF-induced Ca+ entry, ERK1/2 and PLCγ1 activation, and calcium-activated KCa3.1 potassium channel function, all molecular pathways involved in astrocyte proliferation stimulation. Interestingly, MLC1 did not influence AKT, an EGFR-stimulated kinase involved in cell survival. Moreover, EGFR expressionwas higher inmacrophages derived fromMLC patients than fromhealthy individuals. Since reactive astrocytes proliferate and re-express EGFR in response to different pathological stimuli, the present findings provide new information on MLC pathogenesis and unravel an important role for MLC1 in other brain pathological conditions where astrocyte activation occurs.

UR - http://www.scopus.com/inward/record.url?scp=84963764876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963764876&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddw032

DO - 10.1093/hmg/ddw032

M3 - Article

AN - SCOPUS:84963764876

VL - 25

SP - 1543

EP - 1558

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 8

M1 - ddw032

ER -